HemoCath™ is a breakthrough medical device that will transform heart failure (HF) management. It is uniquely designed to be an easy-to-use flow-directed pulmonary artery catheter providing PRECISE and IMMEDIATE metrics of fluid status in HF patients. 

​HemoCath will allow clinicians to accurately MONITOR the two most important measures of fluid status in HF patients  —  pulmonary artery (PA) pressure and central venous pressure (CVP).  

HemoCath Uniquely Designed for Save and Effective Heart Failure Management  

​​​Precise and immediate metrics of fluid status in HF patients will allow more accurate medication dosing  –  Improving patient outcomes  –  Reducing hospitalizations and 30-day readmissions. 

HemoCath Designed to be Easily Available to Patients

HemoCath will be inserted temporarily in a vein in the upper arm by nurses. In most cases, there should be no need for an operating room or medical imaging.